Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study

NCT04325893 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04325893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Terminated
Start date
April 1, 2020
Completion date
June 18, 2020
Enrollment
259 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus